Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People with Sarcoma
Recruiting at 8 trial locations
MB
YA
Overseen ByYesne Alici, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Memorial Sloan Kettering Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to investigate the feasibility of early access to mental healthcare during sarcoma treatment as well as to assess the association between early access to psychiatric care and depression, anxiety, postoperative outcomes, and patient satisfaction in patients undergoing surgery for musculoskeletal sarcoma.
Research Team
MB
Meredith Bartelstein, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Eligibility Criteria
Inclusion Criteria
You are 18 years old or older.
You have been diagnosed with a specific type of cancer in your bones or soft tissues.
Currently seeing an orthopedic surgeon.
See 5 more
Treatment Details
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Early Psychiatric ReferralExperimental Treatment1 Intervention
Participants will be randomized to the Early Psychiatric Referral group
Group II: No ReferralActive Control1 Intervention
Participants will be randomized to the No Referral group
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor
Trials
1,998
Recruited
602,000+
Other People Viewed
By Subject
By Trial
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.